Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
naltrexone (revia) (2019)
docetaxel (taxotere) (1 trial)
gimeracil (1 trial)
oteracil (1 trial)
oxaliplatin (eloxatin) (1 trial)
s-1 (1 trial)
tegafur (1 trial)
Esophageal Neoplasms (Phase 1)
Stomach Neoplasms (Phase 1)
Trials (1 total)
Trial APIs (6 total)